Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6 Myelodysplastic Syndromes 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Leukemia, Myeloid, Acute 4 Graft vs Host Disease 4 Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Myocarditis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Arthritis 1 Anemia, Refractory 1

Interventions

rozanolixizumab 11 efgartigimod alfa 10 zilucoplan 8 Prednisone 8 Cyclophosphamide 8 ravulizumab 7 Rituximab 7 Pyridostigmine Bromide 7 telitacicept 6 fludarabine 6 Tacrolimus 6 Mycophenolic Acid 6 eculizumab 5 Immunoglobulins, Intravenous 5 Hizentra 4 Azathioprine 4 Steroids 3 HBM9161 3 Data Collection 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Exercise 2 Diagnostic Self Evaluation 2 Blood Specimen Collection 2 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Abatacept × Clear all

NCT03059888 2019-11-22

Trial of Orencia in Patients With Myasthenia Gravis

Johns Hopkins University

Phase EARLY_PHASE1 Terminated

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡